Bos and coauthors investigate the relationship between intracranial carotid artery calcification as a marker of intracranial atherosclerosis and the risk of stroke in a white population.
Continuing Medical Education
Hughes and colleagues quantitatively evaluate the performance of Alzheimer disease centers by analyzing copublication networks among the centers.
Graphic Jump Location
Jackson et al determine the diagnostic accuracy of a prototype blood test for variant Creutzfeldt-Jakob disease and its suitability for clinical use and screening prion-exposed populations.
Shulman and colleagues evaluate 18 candidate single-nucleotide polymorphisms to determine whether Parkinson disease susceptibility loci are associated with parkinsonism or substantia nigra pathology.
Cohen and coauthors collect data from patients with multiple sclerosis (MS) switching from natalizumab to fingolimod. They performed a survey-based, observational multicenter cohort study among MS tertiary referral centers. Main outcomes and measures were the occurrence of MS relapse during the washout period or during a 6-month follow-up period after the initiation of fingolimod.
Grossman et al conduct a case-control study using phosphorylated tau to identify a biomarker for amyotrophic lateral sclerosis (ALS).
Cady and coauthors investigate whether p.R47H (rs75932628) in TREM2 is a risk factor for amyotrophic lateral sclerosis and assess whether TREM2 expression is dysregulated in disease.
Yoo and colleagues evaluate the incidence of brief ictal rhythmic discharges in critically ill patients and investigate their association with seizures and outcomes.
Videnovic et al examine the endogenous circadian rhythm of melatonin secretion in patients with Parkinson disease and healthy control individuals using a modified constant routine protocol to assess human endogenous rhythmicity.
Cadieux-Dion and coauthors map and identify the causative gene in a large French-Canadian family with autosomal dominant spinocerebellar ataxia and erythrokeratodermia variabilis.
Skillbäck and colleagues test the diagnostic performance of dementia cerebrospinal fluid biomarkers total tau (T-tau), phosphorylated tau (P-tau), and the T-tau to P-tau ratio for Creutzfeldt-Jakob disease.
Uflacker et al describe the use of preimplantation genetic diagnosis and in vitro fertilization for the prevention of genetic prion disease in the children of a 27-year-old asymptomatic woman with a family history of Gerstmann-Sträussler-Scheinker syndrome.
Thank you for submitting a comment on this article. It will be reviewed by JAMA Neurology editors. You will be notified when your comment has been published. Comments should not exceed 500 words of text and 10 references.
Do not submit personal medical questions or information that could identify a specific patient, questions about a particular case, or general inquiries to an author. Only content that has not been published, posted, or submitted elsewhere should be submitted. By submitting this Comment, you and any coauthors transfer copyright to the journal if your Comment is posted.
* = Required Field
Disclosure of Any Conflicts of Interest*
Indicate all relevant conflicts of interest of each author below, including all relevant financial interests, activities, and relationships within the past 3 years including, but not limited to, employment, affiliation, grants or funding, consultancies, honoraria or payment, speakers’ bureaus, stock ownership or options, expert testimony, royalties, donation of medical equipment, or patents planned, pending, or issued. If all authors have none, check "No potential conflicts or relevant financial interests" in the box below. Please also indicate any funding received in support of this work. The information will be posted with your response.
Some tools below are only available to our subscribers or users with an online account.
Download citation file:
Customize your page view by dragging & repositioning the boxes below.
More Listings atJAMACareerCenter.com >
Enter your username and email address. We'll send you a link to reset your password.
Enter your username and email address. We'll send instructions on how to reset your password to the email address we have on record.
Athens and Shibboleth are access management services that provide single sign-on to protected resources. They replace the multiple user names and passwords necessary to access subscription-based content with a single user name and password that can be entered once per session. It operates independently of a user's location or IP address. If your institution uses Athens or Shibboleth authentication, please contact your site administrator to receive your user name and password.